Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$1.71 - $3.61 $32,710 - $69,055
-19,129 Reduced 65.63%
10,016 $0
Q3 2022

Nov 01, 2022

SELL
$1.9 - $8.63 $10,750 - $48,828
-5,658 Reduced 16.26%
29,145 $71,000
Q2 2022

Aug 17, 2022

BUY
$2.13 - $9.01 $12,628 - $53,420
5,929 Added 20.53%
34,803 $84,000
Q1 2022

May 27, 2022

SELL
$6.28 - $15.59 $640 - $1,590
-102 Reduced 0.35%
28,874 $213,000
Q4 2021

May 26, 2022

BUY
$14.7 - $28.67 $425,947 - $830,741
28,976 New
28,976 $442,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.